Research programme: PPAR modulators - AbGenomics

Drug Profile

Research programme: PPAR modulators - AbGenomics

Alternative Names: AbGn-L; AbGn-X

Latest Information Update: 17 Jun 2011

Price : $50

At a glance

  • Originator AbGenomics Corporation
  • Class
  • Mechanism of Action Peroxisome proliferator-activated receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Metabolic disorders; Type 2 diabetes mellitus

Most Recent Events

  • 04 Aug 2005 Preclinical trials in Type-2 diabetes mellitus in Taiwan (unspecified route)
  • 04 Aug 2005 Preclinical trials in Metabolic disorders in Taiwan (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top